Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome | Zendy

Richard S. Legro | Zendy; Robert G. Brzyski | Zendy; Michael P. Diamond | Zendy; Christos Coutifaris | Zendy; William D. Schlaff | Zendy; Peter R. Casson | Zendy; Gregory M. Christman | Zendy; Hao Huang | Zendy; Qingshang Yan | Zendy; Ruben Alvero | Zendy; Daniel J. Haisenleder | Zendy; Kurt T. Barnhart | Zendy; G. Wright Bates | Zendy; Rebecca Usadi | Zendy; Scott Lucidi | Zendy; Valerie L. Baker | Zendy; J.C. Trussell | Zendy; Stephen A. Krawetz | Zendy; Peter J. Snyder | Zendy; Dana A. Ohl | Zendy; Nanette Santoro | Zendy; Esther Eisenberg | Zendy; Heping Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome

Author(s) -

Richard S. Legro,

Robert G. Brzyski,

Michael P. Diamond,

Christos Coutifaris,

William D. Schlaff,

Peter R. Casson,

Gregory M. Christman,

Hao Huang,

Qingshang Yan,

Ruben Alvero,

Daniel J. Haisenleder,

Kurt T. Barnhart,

G. Wright Bates,

Rebecca Usadi,

Scott Lucidi,

Valerie L. Baker,

J.C. Trussell,

Stephen A. Krawetz,

Peter J. Snyder,

Dana A. Ohl,

Nanette Santoro,

Esther Eisenberg,

Heping Zhang

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1313517

Subject(s) - medicine , letrozole , polycystic ovary , infertility , gynecology , ovary , female infertility , pregnancy , tamoxifen , cancer , breast cancer , biology , obesity , insulin resistance , genetics

Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research